The integrated stress response in cancer: mechanisms of tumor adaptation and therapeutic targeting
Biochemical Society Transactions · 2026
DOI: 10.1042/bst20250133 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2026. Verfasst von Elias Maldonado und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical and Translational Research, McGill University, Montreal, Canada. Hauptthemen laut MEDLINE: Integrated Stress Response, Neoplasms, Adaptation, Physiological, Stress, Physiological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR), Cancer Research Society (CRS), FRQ | Santé (FRQS).
Abstract (Originalsprache)
Cancer cells face continual stressors, which they must overcome to proliferate and survive in the body. Under these conditions, essential biochemical pathways are disrupted, contributing to various stress responses that either promote adaptation and survival or eventual cell death. The evolutionarily conserved integrated stress response (ISR) is a key adaptive mechanism that transiently rewires the transcriptome and translatome in response to various stressors. While the ISR is activated in healthy cells under moderate stress, cancers especially rely on this pathway to overcome harsh conditions experienced during tumor growth and metastasis. We explore the pro-tumorigenic role of the ISR, along with the upstream stress-sensing kinases that activate it. These include protein kinase R-like endoplasmic reticulum kinase, general control non-derepressible 2, double-stranded RNA-dependent protein kinase, and heme-regulated eukaryotic translation initiation factor 2α kinase (HRI), which initiate an ISR in response to diverse stressors by phosphorylating their shared substrate, eukaryotic initiation factor-2α. An in-depth understanding of the pro-survival functions of the ISR and the contexts in which it is pro-tumorigenic is necessary to leverage the ISR as a therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical and Translational Research, McGill University, Montreal, Canada.
- Lady Davis Institute for Medical Research, McGill University, Montreal, Canada.
- Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada.
- Department of Biochemistry, McGill University, Montreal, Canada.
ORCID-Profile: Elias Maldonado, Emily McIsaac, Josie Ursini-Siegel
Förderung
- Canadian Institutes of Health Research (CIHR)
- Cancer Research Society (CRS)
- FRQ | Santé (FRQS)
Zitieren
APA
Maldonado, E., McIsaac, E., & Ursini-Siegel, J. (2026). The integrated stress response in cancer: mechanisms of tumor adaptation and therapeutic targeting. Biochemical Society Transactions. https://doi.org/10.1042/bst20250133
Vancouver
Maldonado E, McIsaac E, Ursini-Siegel J. The integrated stress response in cancer: mechanisms of tumor adaptation and therapeutic targeting. Biochemical Society Transactions. 2026. doi:10.1042/bst20250133
BibTeX
@article{Maldonado2026,
author = {Maldonado, Elias and McIsaac, Emily and Ursini-Siegel, Josie},
title = {The integrated stress response in cancer: mechanisms of tumor adaptation and therapeutic targeting},
journal = {Biochemical Society Transactions},
year = {2026},
doi = {10.1042/bst20250133}
}
EUVIMED